Enanta Pharmaceuticals
ENTA
ENTA
193 hedge funds and large institutions have $1.75B invested in Enanta Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 75 increasing their positions, 57 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
7% more funds holding
Funds holding: 181 → 193 (+12)
1.34% more ownership
Funds ownership: 76.95% → 78.29% (+1.3%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
193
Holding in Top 10
2
Calls
$11.5M
Puts
$8.92M
Top Buyers
| 1 | +$62.2M | |
| 2 | +$26.7M | |
| 3 | +$18.6M | |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$18.5M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$9.9M |
Top Sellers
| 1 | -$42.6M | |
| 2 | -$35M | |
| 3 | -$25.6M | |
| 4 |
Man Group
London,
United Kingdom
|
-$17.1M |
| 5 |
Millennium Management
New York
|
-$9.97M |